API Corporation

API Corporation is owned by Mitsubishi Tanabe Pharma.

Mitsubishi Tanabe Pharma is a company listed under the stock ticker 4508 (JP).

Mitsubishi Tanabe Pharma has a direct presence in 4 countries.

Mitsubishi Tanabe Pharma has 5 subsidiaries including API Corporation, Mitsubishi Tanabe Pharma America and Mitsubishi Tanabe Pharma Development America.

View the org chart displaying its 6 main executives

Most searched biographies at API Corporation

• Hideki Kitadai, President and Chief Executive Officer
• Hiroki Tatemoto, Director of the Board
• Yoshitaka Onzuka, Director

Create your alert
to follow the executive moves at API Corporation.

Mitsubishi Tanabe Pharma has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by API Corporation

• Mitsubishi Chemical Group to Transfer API Corporation Shares | News Releases | Mitsubishi Chemical Group Corporation

Social media about API Corporation

• API Corporation on Wikipedia, Google News & Yahoo Finance
• API Corporation on LinkedIn, Twitter & YouTube

Call API Corporation at +81 35...

View the org chart

Register to receive your alert

Report an error